Granulocyte transfusions in hematologic malignancy patients with invasive pulmonary aspergillosis: outcomes and complications

par Raad, I. I., Chaftari, A. M., Al Shuaibi, M. M., Jiang, Y., Shomali, W., Cortes, J. E., Lichtiger, B., Hachem, R. Y.
Publié dans Ann Oncol (2013)

Differential depth of treatment response required for optimal outcome in patients with blast phase versus chronic phase of chronic myeloid leukemia

par Chen, Z, Medeiros, L J, Kantajian, H M, Zheng, L, Gong, Z, Patel, K P, Xiong, H, Wang, W, Cortes, J E, Hu, S
Publié dans Blood Cancer J (2017)

Low incidence of peripheral arterial disease in patients receiving dasatinib in clinical trials

par le Coutre, P D, Hughes, T P, Mahon, F-X, Kim, D-W, Steegmann, J L, Shah, N P, Gooden, K, Wallis, N, Cortes, J E
Publié dans Leukemia (2016)

Clinical and prognostic significance of e1a2 BCR-ABL1 transcript subtype in chronic myeloid leukemia

par Gong, Z, Medeiros, L J, Cortes, J E, Zheng, L, Khoury, J D, Wang, W, Tang, G, Loghavi, S, Luthra, R, Yang, W, Kantarjian, H M, Hu, S
Publié dans Blood Cancer J (2017)

Differential clinical and prognostic impact of myeloid sarcoma vs medullary myeloid blast phase of chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapy

par Chen, Z, Wang, W, Cortes, J E, Liu, E, Miranda, R N, Zhao, C, Yuan, J, Lu, X, Yang, W, Ameri, M D, Kantarjian, H M, Medeiros, L J, Hu, S
Publié dans Blood Cancer J (2016)

A randomized trial of a single-dose rasburicase versus five-daily doses in patients at risk for tumor lysis syndrome

par Vadhan-Raj, S., Fayad, L. E., Fanale, M. A., Pro, B., Rodriguez, A., Hagemeister, F. B., Bueso-Ramos, C. E., Zhou, X., McLaughlin, P. W., Fowler, N., Shah, J., Orlowski, R. Z., Samaniego, F., Wang, M., Cortes, J. E., Younes, A., Kwak, L. W., Sarlis, N. J., Romaguera, J. E.
Publié 2012

A Phase 2 Trial of Ponatinib in Philadelphia Chromosome–Positive Leukemias

par Cortes, J.E., Kim, D.-W., Pinilla-Ibarz, J., le Coutre, P., Paquette, R., Chuah, C., Nicolini, F.E., Apperley, J.F., Khoury, H.J., Talpaz, M., DiPersio, J., DeAngelo, D.J., Abruzzese, E., Rea, D., Baccarani, M., Müller, M.C., Gambacorti-Passerini, C., Wong, S., Lustgarten, S., Rivera, V.M., Clackson, T., Turner, C.D., Haluska, F.G., Guilhot, F., Deininger, M.W., Hochhaus, A., Hughes, T., Goldman, J.M., Shah, N.P., Kantarjian, H.
Publié 2013

European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia

par Hochhaus, A., Baccarani, M., Silver, R. T., Schiffer, C., Apperley, J. F., Cervantes, F., Clark, R. E., Cortes, J. E., Deininger, M. W., Guilhot, F., Hjorth-Hansen, H., Hughes, T. P., Janssen, J. J. W. M., Kantarjian, H. M., Kim, D. W., Larson, R. A., Lipton, J. H., Mahon, F. X., Mayer, J., Nicolini, F., Niederwieser, D., Pane, F., Radich, J. P., Rea, D., Richter, J., Rosti, G., Rousselot, P., Saglio, G., Saußele, S., Soverini, S., Steegmann, J. L., Turkina, A., Zaritskey, A., Hehlmann, R.
Publié dans Leukemia (2020)

Asciminib in Chronic Myeloid Leukemia after ABL Kinase Inhibitor Failure

par Hughes, T.P., Mauro, M.J., Cortes, J.E., Minami, H., Rea, D., DeAngelo, D.J., Breccia, M., Goh, Y.-T., Talpaz, M., Hochhaus, A., le Coutre, P., Ottmann, O., Heinrich, M.C., Steegmann, J.L., Deininger, M.W.N., Janssen, J.J.W.M., Mahon, F.-X., Minami, Y., Yeung, D., Ross, D.M., Tallman, M.S., Park, J.H., Druker, B.J., Hynds, D., Duan, Y., Meille, C., Hourcade-Potelleret, F., Vanasse, K.G., Lang, F., Kim, D.-W.
Publié dans N Engl J Med (2019)